MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
MADAOCHENGGONG is live on WEEX, offering a 50,000 USDT airdrop for newcomers.
BNP Paribas: If Supreme Court Overturns Trump Tariffs, Dollar May Fall
Current mainstream CEX and DEX funding rate displays market shifting towards bearishness
Cysic Foundation: Airdrop Eligibility Check Tool Now Live
WSJ: Investors are Wary of a New Round of the "Crypto Winter"
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]